SCHEMBL8631320

SCHEMBL8631320

Cc1ncsc1C(O)c1cccc(N(C)C)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.37
TSHR P16473 1/20 0.37
SLC6A3 Q01959 3/20 0.35
CYP3A4 P08684 2/20 0.35
CYP2D6 P10635 2/20 0.35
SLC6A2 P23975 2/20 0.35
SLC6A4 P31645 2/20 0.35
PLK1 P53350 1/20 0.32
ABL1 P00519 1/20 0.32
BCR P11274 1/20 0.32
FYN P06241 1/20 0.31
KDM4E B2RXH2 4/20 0.31
ROCK2 O75116 1/20 0.31
P2RX7 Q99572 1/20 0.31
NPC1 O15118 1/20 0.31
TP53 P04637 1/20 0.31
MAPT P10636 1/20 0.31
RAB9A P51151 1/20 0.31
GFER P55789 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9025658 0.82 IDO1 (0.38) SLC6A3KDM4EP2RX7MAPTLMNA
SCHEMBL8632333 0.81 ADRB1 (0.41) TSHRSLC6A3KDM4ERAB9ALMNA
SCHEMBL8630297 0.81 PFKFB3 (0.38) ALDH1A1TSHRSLC6A3CYP3A4CYP2D6
SCHEMBL8634093 0.80 BRD4 (0.43) SLC6A2SLC6A4P2RX7
SCHEMBL8631276 0.80 BRD4 (0.41) SLC6A3CYP3A4ROCK2NOS2
SCHEMBL2593085 0.79 SLC6A3 (0.44) ALDH1A1SLC6A3KDM4ESMN1; SMN2LMNA
SCHEMBL8629437 0.78 BRD4 (0.45) TSHR
SCHEMBL8656491 0.78 TP53 (0.40) SLC6A3P2RX7TP53
SCHEMBL9026792 0.77 KMT2A (0.48) ALDH1A1SMN1; SMN2
SCHEMBL8629582 0.75 KMT2A (0.46) ALDH1A1TSHRSLC6A3CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5712299-A TREATMENT OF NEURODEGENERATIVE DISORDERS ASTRA AKTIEBOLAG (SE) 1998-01-27 US claimed
EP-0707574-A1 NOVEL (1-PHENYL-1-HETEROCYCLYL)METHANOL AND (1-PHENYL-1-HETEROCYCLYL)METHYLAMINE DERIVATIVES Astra Aktiebolag (SE) 1996-04-24 EP claimed
WO-1995001968-A1 NOVEL (1-PHENYL-1-HETEROCYCLYL)METHANOL AND (1-PHENYL-1-HETEROCYCLYL)METHYLAMINE DERIVATIVES ASTRA AKTIEBOLAG (SE) 1995-01-19 WO claimed
US-5712299-A TREATMENT OF NEURODEGENERATIVE DISORDERS ASTRA AKTIEBOLAG (SE) 1998-01-27 US disclosed
EP-0707574-A1 NOVEL (1-PHENYL-1-HETEROCYCLYL)METHANOL AND (1-PHENYL-1-HETEROCYCLYL)METHYLAMINE DERIVATIVES Astra Aktiebolag (SE) 1996-04-24 EP disclosed
WO-1995001968-A1 NOVEL (1-PHENYL-1-HETEROCYCLYL)METHANOL AND (1-PHENYL-1-HETEROCYCLYL)METHYLAMINE DERIVATIVES ASTRA AKTIEBOLAG (SE) 1995-01-19 WO disclosed